About Teliqon Pharmaceutical Private Limited
Data last updated:
Teliqon Pharmaceutical Private Limited is a private limited company based in Delhi, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2020PTC364984.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Ram Nivas Mishra and Rubi Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ruchi Singh Plot No 03 Kh No 228/2 Groun Floor Manav Kunj Street No – 18 Mukandpur, Delhi, India – 110042.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.2 Lakh, a decline of 20% compared to the previous year. For the same year it recorded a net profit of ₹1,461 (net margin 0.3%) and EBITDA of ₹4,251 (EBITDA margin 0.8%). Revenue has declined at a compounded annual rate (CAGR) of 24% over three years.
The company is associated with 1 brand: Teliqon Pharmaceutical.
For more details, the company can be reached via its website teliqonpharma.com.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressRuchi Singh Plot No 03 Kh No 228/2 Groun Floor Manav Kunj Street No – 18 Mukandpur, Delhi, India – 110042
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Teliqon Pharmaceutical Private Limited
The main business activity of Teliqon Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Teliqon Pharmaceutical Private Limited FY 2025 filings available
Teliqon Pharmaceutical Private Limited reported revenue of ₹5.2 Lakh (down 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Teliqon Pharmaceutical Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 24% over three years, including a 20% fall in the latest year. EBITDA fell 75% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Teliqon Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4,251 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1,461 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Teliqon Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Teliqon Pharmaceutical are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Teliqon Pharmaceutical Private Limited
Teliqon Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Proptunity Private Limited | •••• | •••• | •••• | •••• | - | Ahmedabad, Gujarat, India |
| Miracle Furnish Private Limited | •••• | •••• | •••• | •••• | - | Bhiwani, Haryana, India |
| Ferne Secure Private Limited | •••• | •••• | •••• | •••• | - | Lucknow, Uttar Pradesh, India |
| GD Retail Private Limited | •••• | •••• | •••• | •••• | - | Kancheepuram, Tamil Nadu, India |
| Shriyedoba Farmer Producer Company Limited | •••• | •••• | •••• | •••• | - | Hingoli, Maharashtra, India |
| Teliqon Pharmaceutical Private Limited this company | •••• | •••• | •••• | •••• | - | Delhi, India |
| Sanurti Textiles Private Limited | •••• | •••• | •••• | •••• | - | Thane, Maharashtra, India |
| R K Filaments Private Limited | •••• | •••• | •••• | •••• | - | Surat, Gujarat, India |
| Spoxy Vintrade Private Limited | •••• | •••• | •••• | •••• | - | Kolkata, West Bengal, India |
| Ganesha Trade Exim Private Limited | •••• | •••• | •••• | •••• | - | Kolkata, West Bengal, India |
| TCST Building Solutions India Private Limited | •••• | •••• | •••• | •••• | - | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Teliqon Pharmaceutical by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Board of Directors of Teliqon Pharmaceutical Private Limited
Teliqon Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ram Nivas Mishra | Director | 18 Jun 2020 | 6 Years 3 Months | Current |
| Rubi Kumari | Director | 18 Jun 2020 | 6 Years 3 Months | Current |
Charges & Borrowings of Teliqon Pharmaceutical Private Limited
Teliqon Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Associated Brands with Teliqon Pharmaceutical Private Limited
Teliqon Pharmaceutical operates one associated brand: Teliqon Pharmaceutical. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical products and services in healthcare sectors in India. | teliqonpharma.com |
Employees and EPFO Compliance at Teliqon Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Teliqon Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Teliqon Pharmaceutical Private Limited
Teliqon Pharmaceutical Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Ram Nivas Mishra was appointed as Director on 18 Jun 2020.
Credit Ratings, Litigation & Regulatory Alerts for Teliqon Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Teliqon Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Teliqon Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Teliqon Pharmaceutical Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Teliqon Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Teliqon Pharmaceutical Private Limited
Teliqon Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 June 2020 (6+ years old) and is registered under CIN U51909DL2020PTC364984.
Teliqon Pharmaceutical reported revenue of ₹5.2 Lakh for FY 2025 (down 20% YoY).
Teliqon Pharmaceutical has 2 current directors:
- Ram Nivas Mishra - Director
- Rubi Kumari - Director
Teliqon Pharmaceutical reported a net profit of ₹1,461 (net margin 0.3%) and EBITDA of ₹4,251 (EBITDA margin 0.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Teliqon Pharmaceutical is -24% over three years. In the latest year (FY 2025) revenue fell 20%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Teliqon Pharmaceutical is U51909DL2020PTC364984. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Teliqon Pharmaceutical was incorporated on 18 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Teliqon Pharmaceutical by revenue are Proptunity Private Limited, Miracle Furnish Private Limited, Ferne Secure Private Limited, GD Retail Private Limited, Shriyedoba Farmer Producer Company Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Ram Nivas Mishra was appointed as Director on 18 Jun 2020. Rubi Kumari was appointed as Director on 18 Jun 2020.
Yes, Teliqon Pharmaceutical is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Teliqon Pharmaceutical can be reached through the website teliqonpharma.com. Its registered office is in Delhi, India.